Compliance & Validation — Not documented by Atlas
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
Medical affairs technology and services group whose iEnvision platform adds AI-assisted, human-in-the-loop evidence and publication workflows.
Envision Pharma Group, founded in 2001 and headquartered in Horsham, United Kingdom, is a global medical affairs technology and scientific communications company whose iEnvision platform supports publication planning, evidence generation, grants, and AI-assisted human-in-the-loop literature review. The company has been owned by private equity firms GHO Capital and Ardian since 2016, with the founding management team continuing to operate it, and reports partnerships with over 400 life sciences companies. It is substantially a services business with technology attached, so clarify the software-versus-services split for your use case.
50% — Partial coverage. Coverage score — how completely Atlas documents Envision Pharma Group across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
cloud
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Mid-Size Biotech, Large Pharma, Top 20 Pharma, Medical Affairs
Natural Language Processing
Private equity, Founded 2001
Not captured in Atlas data — confirm directly. Excluded from the score above.
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?